Taylor AJ - Search Results

1

Paradoxical progression of atherosclerosis related to low-density lipoprotein reduction and exposure to ezetimibe.

Taylor AJ, Villines TC, Stanek EJ. Taylor AJ, et al. Eur Heart J. 2012 Dec;33(23):2939-45. doi: 10.1093/eurheartj/ehs105. Epub 2012 May 7. Eur Heart J. 2012. PMID: 22564353 Clinical Trial.

2

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M. Taylor AJ, et al. N Engl J Med. 2009 Nov 26;361(22):2113-22. doi: 10.1056/NEJMoa0907569. Epub 2009 Nov 15. N Engl J Med. 2009. PMID: 19915217 Free article. Clinical Trial.

3

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.

Villines TC, Stanek EJ, Devine PJ, Turco M, Miller M, Weissman NJ, Griffen L, Taylor AJ. Villines TC, et al. Among authors: taylor aj. J Am Coll Cardiol. 2010 Jun 15;55(24):2721-6. doi: 10.1016/j.jacc.2010.03.017. J Am Coll Cardiol. 2010. PMID: 20399059 Free article. Clinical Trial.

4

The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project.

Simprini LA, Villines TC, Rich M, Taylor AJ. Simprini LA, et al. Among authors: taylor aj. J Clin Lipidol. 2012 Mar-Apr;6(2):174-9. doi: 10.1016/j.jacl.2011.11.005. Epub 2011 Dec 3. J Clin Lipidol. 2012. PMID: 22385551 Clinical Trial.

5

The triple line pattern on carotid intima media thickness imaging and its relationship to cardiovascular risk factors in patients on lipid lowering therapy.

Singh TA, Villines TC, Taylor AJ. Singh TA, et al. Among authors: taylor aj. Vasc Health Risk Manag. 2014 Jun 20;10:363-6. doi: 10.2147/VHRM.S47538. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 25018635 Free PMC article. Clinical Trial.

6

Non-invasive atherosclerosis imaging: use to assess response to novel or combination lipid therapies.

Villines TC, Taylor AJ. Villines TC, et al. Among authors: taylor aj. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec;5(6):557-64. doi: 10.2174/156800605774962059. Curr Drug Targets Cardiovasc Haematol Disord. 2005. PMID: 16503876 Review.

7

Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study.

Villines TC, O'Malley PG, Feuerstein IM, Thomas S, Taylor AJ. Villines TC, et al. Among authors: taylor aj. Calcif Tissue Int. 2009 Dec;85(6):494-500. doi: 10.1007/s00223-009-9300-4. Epub 2009 Oct 22. Calcif Tissue Int. 2009. PMID: 19847375

8

Flushing and the HDL-C response to extended-release niacin.

Taylor AJ, Stanek EJ. Taylor AJ, et al. J Clin Lipidol. 2008 Aug;2(4):285-8. doi: 10.1016/j.jacl.2008.05.002. Epub 2008 May 16. J Clin Lipidol. 2008. PMID: 21291745

9

The perimenopausal atherosclerosis transition: relationships between calcified and noncalcified coronary, aortic, and carotid atherosclerosis and risk factors and hormone levels.

Munir JA, Wu H, Bauer K, Bindeman J, Byrd C, Feuerstein IM, Villines TC, Taylor AJ. Munir JA, et al. Among authors: taylor aj. Menopause. 2012 Jan;19(1):10-5. doi: 10.1097/gme.0b013e318221bc8d. Menopause. 2012. PMID: 21900851

10

Multi-ethnic study of atherosclerosis arterial age versus framingham 10-year or lifetime cardiovascular risk.

Villines TC, Taylor AJ. Villines TC, et al. Among authors: taylor aj. Am J Cardiol. 2012 Dec 1;110(11):1627-30. doi: 10.1016/j.amjcard.2012.07.018. Epub 2012 Aug 23. Am J Cardiol. 2012. PMID: 22921999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,094 results

Search Page